Found: 19
Select item for more details and to access through your institution.
Combining Radiation- with Immunotherapy in Prostate Cancer: Influence of Radiation on T Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 14, p. 7922, doi. 10.3390/ijms23147922
- By:
- Publication type:
- Article
T Cell Mediated Conversion of a Non-Anti-La Reactive B Cell to an Autoreactive Anti-La B Cell by Somatic Hypermutation †.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1198, doi. 10.3390/ijms22031198
- By:
- Publication type:
- Article
Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.970457
- By:
- Publication type:
- Article
Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-01572-4
- By:
- Publication type:
- Article
"UniCAR"-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-59082-4
- By:
- Publication type:
- Article
An oligo-His-tag of a targeting module does not influence its biodistribution and the retargeting capabilities of UniCAR T cells.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47044-4
- By:
- Publication type:
- Article
Characterization of a Novel Single-Chain Bispecific Antibody for Retargeting of T Cells to Tumor Cells via the TCR Co-Receptor CD8.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0095517
- By:
- Publication type:
- Article
A Novel <i>Ex Vivo</i> Isolation and Expansion Procedure for Chimeric Antigen Receptor Engrafted Human T Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0093745
- By:
- Publication type:
- Article
Midostaurin abrogates CD33‐directed UniCAR and CD33‐CD3 bispecific antibody therapy in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 5, p. 735, doi. 10.1111/bjh.15975
- By:
- Publication type:
- Article
Theranostic CAR T cell targeting: A brief review.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 8, p. 533, doi. 10.1002/jlcr.3727
- By:
- Publication type:
- Article
Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy.
- Published in:
- Scientific Reports, 2017, p. 42855, doi. 10.1038/srep42855
- By:
- Publication type:
- Article
Conventional CARs versus modular CARs.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 10, p. 1713, doi. 10.1007/s00262-019-02399-5
- By:
- Publication type:
- Article
Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1401, doi. 10.1007/s00262-019-02376-y
- By:
- Publication type:
- Article
Cancer Immunotherapy by Retargeting of Immune Effector Cells via Recombinant Bispecific Antibody Constructs.
- Published in:
- Antibodies (2073-4468), 2012, v. 1, n. 2, p. 172, doi. 10.3390/antib1020172
- By:
- Publication type:
- Article
Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial Strategy.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4785, doi. 10.3390/cancers13194785
- By:
- Publication type:
- Article
Adaptor CAR Platforms—Next Generation of T Cell-Based Cancer Immunotherapy.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1302, doi. 10.3390/cancers12051302
- By:
- Publication type:
- Article
Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab<sup>®</sup>.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 5515, doi. 10.2147/OTT.S245169
- By:
- Publication type:
- Article
Redirection of CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA<sup>+</sup> prostate tumor cells.
- Published in:
- Prostate, 2014, v. 74, n. 13, p. 1347, doi. 10.1002/pros.22851
- By:
- Publication type:
- Article
Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting system.
- Published in:
- Prostate, 2014, v. 74, n. 13, p. 1335, doi. 10.1002/pros.22850
- By:
- Publication type:
- Article